Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral respiratory infections

T A Walker1, S Khurana, S J Tilden

  • 1Division of Pediatric Critical Care Medicine, University of Alabama at Birmingham.

Pediatric Clinics of North America
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty, Geriatric Impairments, and Quality of Life in Older Cancer Survivors Compared to Age-Matched Non-Cancer Controls.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Genetic diversity and evolutionary relationships of human-derived <i>Ascaris</i> spp. based on mitochondrial markers.

Journal of helminthology·2026
Same author

Solitary fibrous tumour presenting as intussusception.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2024
Same author

Priorities, opportunities, and challenges for integrating microorganisms into Earth system models for climate change prediction.

mBio·2024
Same author

A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG).

Medical oncology (Northwood, London, England)·2023
Same author

Central nervous system infections caused by pathogenic free-living amoebae: An Indian perspective.

Tropical biomedicine·2022

Viral infections cause over 60% of acute lower respiratory illnesses, with respiratory syncytial virus (RSV) being a major cause. While supportive care is standard, new therapies and vaccines offer hope for better outcomes in treating these common viral respiratory infections.

Area of Science:

  • Virology
  • Infectious Diseases
  • Pulmonology

Background:

  • Viral infections account for over 60% of acute lower respiratory illnesses.
  • Respiratory syncytial virus (RSV) and parainfluenza viruses are the most common causes.
  • Viral entry into host cells triggers pathogenetic mechanisms leading to tissue injury and clinical disease.

Purpose of the Study:

  • To review the current understanding of viral respiratory infections.
  • To discuss the limitations of existing treatments.
  • To highlight the potential of novel therapies and vaccines.

Main Methods:

  • Literature review of viral respiratory infections.
  • Analysis of current treatment strategies in intensive care units.
  • Discussion of approved and emerging antiviral agents.

Related Experiment Videos

Main Results:

  • Supportive care remains the primary treatment for viral respiratory illnesses in the ICU.
  • Nonspecific treatments include beta-agonists, aminophylline, and steroids.
  • Ribavirin is the only approved agent for RSV, but its efficacy is debated.

Conclusions:

  • Viral respiratory infections, particularly RSV, pose a significant public health challenge.
  • Current treatments are largely supportive, with limited specific antiviral options.
  • Emerging therapies and vaccines show promise for improving patient outcomes.